Alexander Egeberg

13.1k total citations · 1 hit paper
315 papers, 8.1k citations indexed

About

Alexander Egeberg is a scholar working on Dermatology, Immunology and Immunology and Allergy. According to data from OpenAlex, Alexander Egeberg has authored 315 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 179 papers in Dermatology, 155 papers in Immunology and 68 papers in Immunology and Allergy. Recurrent topics in Alexander Egeberg's work include Psoriasis: Treatment and Pathogenesis (142 papers), Dermatology and Skin Diseases (134 papers) and Allergic Rhinitis and Sensitization (57 papers). Alexander Egeberg is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (142 papers), Dermatology and Skin Diseases (134 papers) and Allergic Rhinitis and Sensitization (57 papers). Alexander Egeberg collaborates with scholars based in Denmark, United States and United Kingdom. Alexander Egeberg's co-authors include Jacob P. Thyssen, Lone Skov, Gunnar Gislason, Peter Riis Hansen, Jashin J. Wu, Y.M.F. Andersen, Lotus Mallbris, Anne‐Sofie Halling, Farzad Alinaghi and Carsten R. Hamann and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Care and Annals of Neurology.

In The Last Decade

Alexander Egeberg

289 papers receiving 7.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies

2018 444 citations Farzad Alinaghi, Lars Erik Kristensen et al. Journal of the American Academy of Dermatology profile →

Peers

Countries citing papers authored by Alexander Egeberg

Since Specialization

Citations

This map shows the geographic impact of Alexander Egeberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Egeberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Egeberg more than expected).

Fields of papers citing papers by Alexander Egeberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Egeberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Egeberg. The network helps show where Alexander Egeberg may publish in the future.

Co-authorship network of co-authors of Alexander Egeberg

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Egeberg. A scholar is included among the top collaborators of Alexander Egeberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Egeberg. Alexander Egeberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-World Evidence of Effectiveness and Safety of Abrocitinib, Baricitinib and Upadacitinib in Atopic Dermatitis: A Systematic Review and Meta-Analysis 2025 ·American Journal of Clinical Dermatology ·Amalie Thorsti Møller Rønnstad, (unknown), Christopher G. Bunick, Raj Chovatiya, (unknown), Farzad Alinaghi, Simon Francis Thomsen, Christian Apfelbacher, Andreas Wollenberg, Alexander Egeberg, Jacob P. Thyssen, Nikolai Loft	0
2	Biologics Used for Psoriasis: A Drug Utilization Study Based on Two Nationwide Danish Data Sources 2024 ·Pharmacoepidemiology and Drug Safety ·(unknown), Jesper Hallas, Peter Jensen, Alexander Egeberg, Mette Reilev	1
3	Biomarkers of systemic inflammation are associated with disease severity and metabolic syndrome in patients with hidradenitis suppurativa 2024 ·JAAD International ·(unknown), (unknown), (unknown), Jacob P. Thyssen, Alexander Egeberg, Signe Holm Nielsen, Hans Christian Ring, Simon Francis Thomsen	8
4	Global Comparison of COVID-19 Vaccination Rates among Psoriasis Patients 2024 ·Life ·(unknown), (unknown), (unknown), Fernando Valenzuela, Ricardo Romiti, (unknown), Alexander Egeberg, Hazel H. Oon, Lara Valeska Maul, (unknown), Kathryn Lee, (unknown), (unknown), (unknown), (unknown), Julia‐Tatjana Maul, April W. Armstrong	0
5	Characteristics of Patients With Psoriasis Treated With Various Biologics – A Danish Cohort Study 2024 ·PubMed ·(unknown), Lone Skov, Alexander Egeberg, (unknown), Jennifer Lee, (unknown), Nikolai Loft	0
6	Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: A nationwide cohort study 2023 ·Journal of the American Academy of Dermatology ·(unknown), (unknown), Mads Kirchheiner Rasmussen, Trine Bertelsen, Tomas Norman Dam, Lone Skov, Lars Erik Bryld, Jashin J. Wu, Simon Francis Thomsen, Jacob P. Thyssen, Alexander Egeberg	5
7	The Association between Fatigue and Adult Atopic Dermatitis: A Cross-Sectional Study 2023 ·Dermatitis ·Jacob P. Thyssen, (unknown), Julia‐Tatjana Maul, Peter Schmid‐Grendelmeier, Jashin J. Wu, (unknown), (unknown), Simon Francis Thomsen, Alexander Egeberg	1
8	Drug survival of biologic therapies for palmoplantar pustulosis: A nationwide study 2023 ·Journal of the European Academy of Dermatology and Venereology ·Trine Bertelsen, Alexander Egeberg, Lone Skov, Mads Kirchheiner Rasmussen, Lars Erik Bryld, Anne T. Funding, (unknown), (unknown)	1
9	41915 Improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata achieving scalp hair regrowth: results from two randomized controlled trials 2023 ·Journal of the American Academy of Dermatology ·Brittany G. Craiglow, Yang Won Lee, Sergio Vañó‐Galván, Alexander Egeberg, Yves Dutronc, Frédérick Durand, Evangeline Pierce, Yuxin Ding, Yun-Fei Chen, Arash Mostaghimi	1
10	42070 Comparison of COVID-19 Vaccination Rates Among Psoriasis Patients Globally Using the Global Healthcare Study on Psoriasis (GHSP) 2023 ·Journal of the American Academy of Dermatology ·(unknown), (unknown), Fernando Valenzuela, Ricardo Romiti, (unknown), Alexander Egeberg, Hazel H. Oon, (unknown), (unknown), (unknown), Kathryn Lee, (unknown), Julia‐Tatjana Maul, April W. Armstrong	0
11	42592 Baseline Characteristics and Interim Month 12 mNAPSI Results in Patients with Moderate-to- Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated with Biologics in the Psoriasis Study of Health Outcomes (PSoHO) 2023 ·Journal of the American Academy of Dermatology ·Alexander Egeberg, Andreas Pinter, Ronald Vender, (unknown), Alan Brnabic, Christopher F. Schuster, (unknown), Catherine Reed, Elisabeth Riedl, L. Puig	1
12	44115 Integrated Safety Analysis of Abrocitinib in 3802 Patients With Moderate-To-Severe Atopic Dermatitis With Over 5000 Patient-Years of Exposure 2023 ·Journal of the American Academy of Dermatology ·Eric L. Simpson, Jonathan I. Silverberg, Audrey Nosbaum, Kevin Winthrop, Emma Guttman‐Yassky, Alexander Egeberg, Haiyun Fan, (unknown), Susan Johnson, (unknown)	1
13	41247 Baseline distribution of eyebrow and eyelash loss by severity of scalp hair loss in phase 3 trials of baricitinib for alopecia areata 2023 ·Journal of the American Academy of Dermatology ·Jerry Shapiro, Justin Ko, Alexander Egeberg, Najwa Somani, Jakub Jedynak, Hitoe Torisu‐Itakura, Guanglei Yu, (unknown), Brittany G. Craiglow	1
14	Incidence, prevalence and risk of acne in adolescent and adult patients with atopic dermatitis: a matched cohort study 2022 ·Journal of the European Academy of Dermatology and Venereology ·Jacob P. Thyssen, (unknown), Julia‐Tatjana Maul, Peter Schmid‐Grendelmeier, Jashin J. Wu, Simon Francis Thomsen, Alexander Egeberg	16
15	Family burden of hospital‐managed pediatric atopic dermatitis: A nationwide registry‐based study 2021 ·Pediatric Allergy and Immunology ·Ida Vittrup, C. Droitcourt, Y.M.F. Andersen, Lone Skov, Alexander Egeberg, (unknown), Miriam C. Fenton, Jacob P. Thyssen	6
16	Awareness and Expectations Surrounding Family Planning and Pregnancy Among Danish Patients with Chronic Inflammatory Disease of the Skin or Joints: Results from an Online Survey 2021 ·Rheumatology and Therapy ·(unknown), Trine Bay Laurberg, Alexander Egeberg, (unknown), (unknown), Lone Skov, Lars Erik Kristensen, Simon Francis Thomsen, Karen Schreiber	3
17	Healthcare utilization in Danish children with atopic dermatitis and parental topical corticosteroid phobia 2020 ·Pediatric Allergy and Immunology ·Trine Gerner, (unknown), Christian Vestergaard, Mette Deleuran, Gregor B. E. Jemec, Charlotte G. Mørtz, Tove Agner, Alexander Egeberg, Lone Skov, Jacob P. Thyssen	15
18	Comorbidities of alopecia areata: a population‐based cohort study 2020 ·Clinical and Experimental Dermatology ·Alexander Egeberg, (unknown), Emily Edson‐Heredia, Russel Burge	27
19	Rosacea is associated with Helicobacter pylori: a systematic review and meta‐analysis 2017 ·Journal of the European Academy of Dermatology and Venereology ·(unknown), Alexander Egeberg, (unknown), Leonard B. Weinstock, Erik P. Thyssen, Jacob P. Thyssen	47
20	Atopic dermatitis is associated with anxiety, depression, and suicidal ideation, but not with psychiatric hospitalization or suicide 2017 ·Allergy ·Jacob P. Thyssen, Carsten R. Hamann, Allan Linneberg, Thomas Meinertz Dantoft, Lone Skov, Gunnar Gislason, Jashin J. Wu, Alexander Egeberg	137

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact